1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Increased uterine prostaglandin E receptors in menorrhagic women
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1988.tb06847.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 95, Issue 2, pages 166–174, February 1988
Additional Information
How to Cite
MACDONALD, R. R., THOROGOOD, J. and MASON, M. K. (1988), Increased uterine prostaglandin E receptors in menorrhagic women. BJOG: An International Journal of Obstetrics & Gynaecology, 95: 166–174. doi: 10.1111/j.1471-0528.1988.tb06847.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 19 March 1987 Accepted 29 May 1987
- Abstract
- References
- Cited By
Summary. A randomized trial was arranged in Yorkshire to assess whether progestogens would improve survival as part of the primary treatment of endometrial carcinoma, in conjunction with surgery and radiotherapy. A total of 429 patients was randomized on diagnosis to the progestogen or control group and treated locally according to an agreed protocol. All the patients are now more than 1 year after operation and over half are more than 5 years after operation. The projected overall 5-year survival rate is 76% but contrary to expectation there is no statistically significant difference in survival between the patients treated with progestogens and the control group even after statistical adjustment for known prognostic factors.